Use of Economic Evaluation in the Listing and Pricing of Pharmaceuticals.
Tae Jin Lee
J Prev Med Public Health. 2008;41(2):69-73. DOI: https://doi.org/10.3961/jpmph.2008.41.2.69
Citations to this article as recorded by
Policy Suggestions to Improve Patient Access to New Drugs in Korea
Yoona Choi, Howard Lee
Korean Journal of Clinical Pharmacy.2021; 31(1): 1. CrossRef
Consistency of new drug pricing in Korea: Bridging variations among personnel in price negotiations
Hye-Young Kwon, Jinhyun Kim
Health Policy.2020; 124(9): 965. CrossRef
How Much Amount of Socioeconomic Loss Is Caused by Digestive Diseases?
Kyung Sik Park
The Korean Journal of Gastroenterology.2011; 58(6): 297. CrossRef
Health Care Costs of Digestive Diseases in Korea
Hye-kyung Jung, BoHyoung Jang, Youn Hee Kim, JooYeon Park, Sun Young Park, Mi-Hee Nam, Myung-Gyu Choi
The Korean Journal of Gastroenterology.2011; 58(6): 323. CrossRef